Arizona Bioscience News: TGen leads CTE study; Core Institute gains $50M; BioSyntagma receives federal grant

January 26, 2017

By Matt Ellsworth

Core instituteInspired by NFL teammate, Aethlon seeks diagnostic for brain injuries / Xconomy

Phoenix-based Translational Genomics Research Institute will be leading a study of up to 200 retired NFL players with the hope it could lead to a simple blood test for diagnosing chronic traumatic encephalopathy, or CTE.

The Core Institute nabs $50M in first round of outside funding / Phoenix Business Journal

The Core Institute, a Phoenix-based orthopedic group, has received about $50 million in its first round of outside financing.

Why, where to get your kids involved in STEM: 8 free events / Arizona Republic

These eight free STEM activities for kids around metro Phoenix this spring are some of the dozens of festivals and events introducing children to science, technology, engineering, and math.

ASU has role in driving Arizona innovation / East Valley Tribune

When scanning the East Valley’s vibrant business-incubator landscape, it can be easy to overlook the granddaddy of them all—Arizona State University.

ASU spinout gets national funding for tissue chip / Phoenix Business Journal

BioSyntagma LLC has received a $213,904 Small Business Innovation Research grant from the National Science Foundation to help the Phoenix company continue to develop its Light Stream FloCell, which allows researchers to understand how disease-causing cells interact.

UA alum brings mass spectrometry testing to Tucson / The Daily Wildcat

Nina Ossanna, former business-development director for University of Arizona’s Bio5 Institute, has co-founded Pharos Diagnostics in Tucson to provide testing for mass spectrometry technology.

Incubators nurture wide array of visionary businesses / East Valley Tribune

The Phoenix area’s East Valley includes incubators and accelerators that are helping startup bioscience and technology companies grow.